Burden of Drug resistant Tuberculosis in newly diagnosed Tuberculosis patients of Khyber Pakhtunkhwa, Pakistan.
Tuberculosis, MDR-TB, XDR-TB, Drug susceptibility test.
Journal
JPMA. The Journal of the Pakistan Medical Association
ISSN: 0030-9982
Titre abrégé: J Pak Med Assoc
Pays: Pakistan
ID NLM: 7501162
Informations de publication
Date de publication:
Mar 2021
Mar 2021
Historique:
entrez:
31
5
2021
pubmed:
1
6
2021
medline:
3
6
2021
Statut:
ppublish
Résumé
To explore the burden of drug-resistant tuberculosis in Khyber Pakhtunkhwa, Pakistan. The cross-sectional study was conducted from March 1, 2016, to February 28, 2017, at the Khyber Pakhtunkhwa Tuberculosis Reference Laboratory, Hayatabad Medical Complex, Peshawar, Pakistan, and comprised referred suspected tuberculosis patient samples. Drug Susceptibility testing on all Mycobacterium tuberculosis complex strains was performed and data was subjected to statistical analysis. Of the 8220 samples, 4230 (51.5%) were related to females and 3990 (48.5%) to males. Also, 1978 (24%) were related to patients aged 15-24 years. Of the total, 1351 (16.5%) samples were positive on culture. Drug susceptibility testing showed 525 (39%) samples to be resistant to at least one of the first- and second-line drugs. Among the culture-positive cases, 5 (0.4%) were extensively drug-resistant, 62 (4.6%) multi-drug resistant, 243 (18%) polyresistant, 215 (16%) monoresistant and 826 (61%) were pan-sensitive. Drug-resistant tuberculosis in newly-diagnosed tuberculosis patients was alarmingly high in Khyber Pakhtunkhwa region.
Identifiants
pubmed: 34057947
pii: 10541
doi: 10.47391/JPMA.08-926
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM